Navigation Links
Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18

equire follow-up each year in the United States. At least 3 million of these results are caused by some type of HPV.

Other Information about GARDASIL

In 1995, Merck entered into a license agreement and research collaboration with CSL Limited of Australia relating to technology used in GARDASIL. GARDASIL also is the subject of other third-party licensing agreements.

Merck recently announced that it submitted a supplemental Biologics License Application (sBLA) to the FDA that includes efficacy data showing GARDASIL offers some protection against additional cervical cancer causing HPV types responsible for greater than 10 percent of cervical cancers, data on protection against additional gynecological cancers -- vulvar and vaginal -- and data on immune memory.

About Merck

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. For more information, visit www.merck.com.

Forward-Looking Statement

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and involve risks and uncertainties, which may cause results to differ materially from those set forth in the statements. The forward-looking statements may include statements regarding product development, product potential or financial performance. No forward-looking statement can be guaranteed and actual results may differ materially from those projected. Merck undertakes no oblig
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
2. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
3. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
4. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
5. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
6. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
7. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
8. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
9. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
10. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
Post Your Comments:
(Date:8/20/2014)... 2014 Transparency Market ... Acid (MCA) Market for Cellulosics, Agrochemicals, Surfactants, Thioglycolic Acid ... Share, Growth, Trends and Forecast 2014 - 2020". The ... million in 2013 and is anticipated to reach USD ... 3.6% during the forecast period from 2014 to 2020. ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com ... available in its catalogue: Global Coatings ... http://www.reportlinker.com/p01375204/Global-Coatings-for-Medical-Devices-Industry.html This report analyzes ... in US$ Million by the following Product Segments: ... Coatings. The report provides separate comprehensive analytics for ...
(Date:8/20/2014)... 2014 Reportlinker.com announces that a new market ... Global Feminine Hygiene Products Industry ... markets for Feminine Hygiene Products in US$ Million by ... and Others. The report provides separate comprehensive analytics for ... Japan , Europe , ...
Breaking Medicine Technology:Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 4Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21Global Feminine Hygiene Products Industry 2Global Feminine Hygiene Products Industry 3Global Feminine Hygiene Products Industry 4Global Feminine Hygiene Products Industry 5Global Feminine Hygiene Products Industry 6Global Feminine Hygiene Products Industry 7Global Feminine Hygiene Products Industry 8Global Feminine Hygiene Products Industry 9Global Feminine Hygiene Products Industry 10Global Feminine Hygiene Products Industry 11Global Feminine Hygiene Products Industry 12Global Feminine Hygiene Products Industry 13
... In an effort to meet industry demands ... safe and accurate administration, B. Braun Medical Inc. ... Cefepime for Injection USP and Dextrose Injection USP ... Delivery System will be available for purchase ...
... Johnson & Johnson (NYSE: JNJ ) will ... on Tuesday, Oct. 19, 2010, to discuss third-quarter financial ... be hosted by Sheri McCoy, Worldwide Chairman, Pharmaceuticals Group; ... and Louise Mehrotra, Vice President, Investor Relations. ...
Cached Medicine Technology:FDA-Approved Cefepime Now Available for Use in B. Braun's DUPLEX® System 2
(Date:8/20/2014)... Aug. 19, 2014 (HealthDay News) -- A group representing ... get a flu shot. According to the American ... in recent years have upheld the safety and effectiveness ... is highly infectious and can be particularly dangerous to ... and other complications," Dr. Laura Riley, chair of the ...
(Date:8/20/2014)... that the immune system is defective in people suffering from ... have ongoing issues with pain. , The research the ... help to explain why some painkillers may not offer satisfactory ... to 10% of the community. There are different forms ... which often has the greatest impact on sufferers, quality of ...
(Date:8/20/2014)... Barbara Bronson Gray HealthDay Reporter ... extremely rare, colds, flu and other minor infections might ... stroke in children, a new study suggests. Just five ... the United States, said Dr. Heather Fullerton, lead author of ... the University of California, San Francisco Benioff Children,s Hospital. "It ...
(Date:8/20/2014)... 2014 The Board of Directors of ... is pleased to announce the expansion of its ... China and the surrounding region. In support of ... AIA has relocated to the firm’s office in ... planning and design and to better support regional clients. ...
(Date:8/20/2014)... City, Utah (PRWEB) August 20, 2014 With ... 500’s 2014 list of the nation’s fastest growing companies. The ... in the health care sector. Connexion Point is the #1 ... contact centers in Medicare and Medicaid, and its clients include ... nation. Connexion Point employs 1,000 people and has offices and ...
Breaking Medicine News(10 mins):Health News:All Pregnant Women Need Flu Shot: Ob/Gyn Group 2Health News:Pain treatments less effective for those with irritable bowel 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 3Health News:Perkins Eastman Expands Presence in China 2Health News:Perkins Eastman Expands Presence in China 3Health News:With 3943.8% Growth, Connexion Point, a Leader in Contact Centers for Health Care, Ranks 86th on the Inc. 500 List as One of the Nation’s Fastest Growing Companies 2
... Wash., April 16 drugstore.com , inc. (Nasdaq: ... vision, and pharmacy products, will announce its financial results for ... April 29, 2009 at 5:00 p.m. ET (2:00 p.m. PT). ... will be distributed via PR Newswire and posted on the ...
... workshops to exchange ideas with experts on clinical ... PRA International, a leading Clinical ... how to manage the challenges posed by current ... marketing approvals, and increase efficiency working with different ...
... and effect , , THURSDAY, April 16 (HealthDay News) -- ... and C in their diet may be at increased risk ... 40 studies conducted between 1980 and 2007 showed that people ... A than those without the disease. The average intake among ...
... Patients and Their Loved OnesMOUNT SHASTA, Calif., April 16 ... sweeter, more mystifying sound than the elusive words SPONTANEOUS REMISSION," ... The semi-Buddhist answer to dancing with Cancer ... YOU LEAD" ... this miraculous phenomenon was not a spontaneous event at all ...
... Abbott/Eisai,s Humira Will Earn Decision Resources, Clinical Gold ... to a New Report from Decision ResourcesWALTHAM, Mass., ... world,s leading research and advisory firms for pharmaceutical ... a therapy,s effect on induction of remission as ...
... Chance to Look Like a Star with Milk on ... Only at bodybymilk.comWASHINGTON , April 16 Warding ... superheroes like Wolverine need a little help. (Photo: ... to rebuild his body far faster than any ordinary ...
Cached Medicine News:Health News:drugstore.com, inc. to Announce First Quarter 2009 Results During Conference Call on Wednesday, April 29, 2009 at 5:00 p.m. ET 2Health News:PRA Hosts Biotech 2009 - Challenges and Opportunities in R&D 2Health News:Low Vitamin E, C Intake Tied to Asthma Risk 2Health News:New Guidebook Uses Buddhist Principles to Combat Cancer 2Health News:For Ulcerative Colitis, Surveyed Experts Indicate That Corticosteroids Have Advantages Over Remicade in the Induction of Remission 2Health News:For Ulcerative Colitis, Surveyed Experts Indicate That Corticosteroids Have Advantages Over Remicade in the Induction of Remission 3Health News:X-Men's Wolverine Depends on Milk as His X-factor 2
For primary and revision cases...
The Protract stem offers a press-fit option which will allow choice of standard or lateralized neck offsets while keeping a consistent leg length....
Standard Erlanger hip stem....
Cemented foundation 460 series....
Medicine Products: